avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irf2
|
ENSMUSG00000031627.7 | interferon regulatory factor 2 |
Irf1
|
ENSMUSG00000018899.10 | interferon regulatory factor 1 |
Irf8
|
ENSMUSG00000041515.3 | interferon regulatory factor 8 |
Irf9
|
ENSMUSG00000002325.8 | interferon regulatory factor 9 |
Irf7
|
ENSMUSG00000025498.8 | interferon regulatory factor 7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Irf1 | mm10_v2_chr11_+_53770458_53770509 | 0.51 | 1.5e-03 | Click! |
Irf7 | mm10_v2_chr7_-_141266415_141266481 | 0.49 | 2.3e-03 | Click! |
Irf2 | mm10_v2_chr8_+_46739745_46739791 | 0.37 | 2.6e-02 | Click! |
Irf8 | mm10_v2_chr8_+_120736352_120736385 | -0.34 | 4.4e-02 | Click! |
Irf9 | mm10_v2_chr14_+_55604550_55604579 | 0.22 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_77729091 | 33.28 |
ENSMUST00000109775.2
|
Apol9b
|
apolipoprotein L 9b |
chr1_+_130826676 | 19.85 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_130826762 | 18.74 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr15_-_77411034 | 17.58 |
ENSMUST00000089452.5
ENSMUST00000081776.3 |
Apol9a
|
apolipoprotein L 9a |
chr2_-_173218879 | 16.47 |
ENSMUST00000109116.2
ENSMUST00000029018.7 |
Zbp1
|
Z-DNA binding protein 1 |
chr4_+_42629719 | 14.27 |
ENSMUST00000166898.2
|
Gm2564
|
predicted gene 2564 |
chr8_-_71537402 | 13.78 |
ENSMUST00000051672.7
|
Bst2
|
bone marrow stromal cell antigen 2 |
chr19_+_34607927 | 13.35 |
ENSMUST00000076249.5
|
I830012O16Rik
|
RIKEN cDNA I830012O16 gene |
chr8_-_45333189 | 12.55 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr19_+_34640871 | 12.19 |
ENSMUST00000102824.3
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr18_+_60212080 | 12.06 |
ENSMUST00000031549.5
|
Gm4951
|
predicted gene 4951 |
chr2_+_122147680 | 11.55 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr19_-_11050500 | 11.53 |
ENSMUST00000099676.4
|
AW112010
|
expressed sequence AW112010 |
chr5_-_105239533 | 11.52 |
ENSMUST00000065588.6
|
Gbp10
|
guanylate-binding protein 10 |
chr11_+_70459940 | 10.96 |
ENSMUST00000147289.1
ENSMUST00000126105.1 |
Zmynd15
|
zinc finger, MYND-type containing 15 |
chr11_+_70459611 | 10.76 |
ENSMUST00000039093.3
|
Zmynd15
|
zinc finger, MYND-type containing 15 |
chr7_-_141010759 | 10.64 |
ENSMUST00000026565.6
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr11_+_49087022 | 10.50 |
ENSMUST00000046704.6
|
Ifi47
|
interferon gamma inducible protein 47 |
chr1_-_162984519 | 10.16 |
ENSMUST00000028010.7
|
Fmo3
|
flavin containing monooxygenase 3 |
chr3_-_151749877 | 9.57 |
ENSMUST00000029671.7
|
Ifi44
|
interferon-induced protein 44 |
chr19_+_34583528 | 9.53 |
ENSMUST00000102825.3
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr16_+_43363855 | 9.38 |
ENSMUST00000156367.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr10_+_40629987 | 9.22 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr16_+_23609895 | 8.61 |
ENSMUST00000038423.5
|
Rtp4
|
receptor transporter protein 4 |
chr8_-_84773381 | 8.45 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr3_-_113574758 | 8.44 |
ENSMUST00000106540.1
|
Amy1
|
amylase 1, salivary |
chr3_-_113574242 | 8.28 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr7_-_141266415 | 8.27 |
ENSMUST00000106023.1
ENSMUST00000097952.2 ENSMUST00000026571.4 |
Irf7
|
interferon regulatory factor 7 |
chr12_+_103434211 | 8.11 |
ENSMUST00000079294.5
ENSMUST00000076788.5 ENSMUST00000076702.5 ENSMUST00000066701.6 ENSMUST00000085065.5 ENSMUST00000140838.1 |
Ifi27
|
interferon, alpha-inducible protein 27 |
chr11_-_53859187 | 8.09 |
ENSMUST00000117316.1
ENSMUST00000120776.1 ENSMUST00000121435.1 |
Gm12216
|
predicted gene 12216 |
chr11_-_49064202 | 8.00 |
ENSMUST00000046745.6
|
Tgtp2
|
T cell specific GTPase 2 |
chr11_-_48992226 | 7.97 |
ENSMUST00000059930.2
ENSMUST00000068063.3 |
Gm12185
Tgtp1
|
predicted gene 12185 T cell specific GTPase 1 |
chr2_+_102706356 | 7.86 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr7_-_14446570 | 7.85 |
ENSMUST00000063509.4
|
2810007J24Rik
|
RIKEN cDNA 2810007J24 gene |
chr15_-_77596110 | 7.77 |
ENSMUST00000089465.4
|
Apol10b
|
apolipoprotein L 10B |
chr15_-_77533312 | 7.74 |
ENSMUST00000062562.5
|
Apol7c
|
apolipoprotein L 7c |
chr9_+_20868628 | 7.64 |
ENSMUST00000043911.7
|
A230050P20Rik
|
RIKEN cDNA A230050P20 gene |
chr7_-_14446651 | 7.58 |
ENSMUST00000125941.1
|
2810007J24Rik
|
RIKEN cDNA 2810007J24 gene |
chr1_+_52119438 | 7.54 |
ENSMUST00000070968.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr17_-_36042690 | 7.44 |
ENSMUST00000058801.8
ENSMUST00000080015.5 ENSMUST00000077960.6 |
H2-T22
|
histocompatibility 2, T region locus 22 |
chr9_-_106476104 | 7.43 |
ENSMUST00000156426.1
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr9_-_106476372 | 7.40 |
ENSMUST00000123555.1
ENSMUST00000125850.1 |
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr17_-_34187219 | 7.36 |
ENSMUST00000173831.1
|
Psmb9
|
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
chr3_+_142620596 | 7.28 |
ENSMUST00000165774.1
|
Gbp2
|
guanylate binding protein 2 |
chr18_+_60376029 | 7.18 |
ENSMUST00000066912.5
ENSMUST00000032473.6 |
Iigp1
|
interferon inducible GTPase 1 |
chr9_-_106476590 | 7.15 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr1_-_173599074 | 7.13 |
ENSMUST00000150649.1
ENSMUST00000180215.1 ENSMUST00000097462.2 |
Pydc4
|
pyrin domain containing 4 |
chr1_+_167618246 | 7.03 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr4_-_42756543 | 6.88 |
ENSMUST00000102957.3
|
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr9_+_77921908 | 6.45 |
ENSMUST00000133757.1
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr16_+_97536079 | 6.44 |
ENSMUST00000024112.7
|
Mx2
|
myxovirus (influenza virus) resistance 2 |
chr17_-_34862122 | 6.41 |
ENSMUST00000154526.1
|
Cfb
|
complement factor B |
chr11_-_48871408 | 6.36 |
ENSMUST00000097271.2
|
Irgm1
|
immunity-related GTPase family M member 1 |
chr5_+_114923234 | 6.34 |
ENSMUST00000031540.4
ENSMUST00000112143.3 |
Oasl1
|
2'-5' oligoadenylate synthetase-like 1 |
chr6_-_23839137 | 6.32 |
ENSMUST00000166458.2
ENSMUST00000142913.2 ENSMUST00000115357.1 ENSMUST00000069074.7 ENSMUST00000115361.2 ENSMUST00000018122.7 ENSMUST00000115355.1 ENSMUST00000115356.2 |
Cadps2
|
Ca2+-dependent activator protein for secretion 2 |
chr11_-_48871344 | 6.30 |
ENSMUST00000049519.3
|
Irgm1
|
immunity-related GTPase family M member 1 |
chr6_-_39118211 | 6.22 |
ENSMUST00000038398.6
|
Parp12
|
poly (ADP-ribose) polymerase family, member 12 |
chr4_-_42773993 | 6.19 |
ENSMUST00000095114.4
|
Ccl21a
|
chemokine (C-C motif) ligand 21A (serine) |
chr11_-_70459957 | 6.16 |
ENSMUST00000019064.2
|
Cxcl16
|
chemokine (C-X-C motif) ligand 16 |
chr1_+_175631996 | 6.00 |
ENSMUST00000040250.8
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chrX_+_59999436 | 6.00 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr11_+_72301613 | 5.99 |
ENSMUST00000151440.1
ENSMUST00000146233.1 ENSMUST00000140842.2 |
Xaf1
|
XIAP associated factor 1 |
chr1_-_150466165 | 5.99 |
ENSMUST00000162367.1
ENSMUST00000161611.1 ENSMUST00000161320.1 ENSMUST00000159035.1 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr11_+_119393060 | 5.94 |
ENSMUST00000131035.2
ENSMUST00000093902.5 |
Rnf213
|
ring finger protein 213 |
chr3_+_142560052 | 5.90 |
ENSMUST00000106222.2
|
Gbp3
|
guanylate binding protein 3 |
chr1_+_175632169 | 5.89 |
ENSMUST00000097458.3
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr1_+_173673651 | 5.86 |
ENSMUST00000085876.4
|
Pydc3
|
pyrin domain containing 3 |
chr17_+_36121666 | 5.67 |
ENSMUST00000173128.1
|
Gm19684
|
predicted gene, 19684 |
chr4_+_42255767 | 5.66 |
ENSMUST00000178864.1
|
Ccl21b
|
chemokine (C-C motif) ligand 21B (leucine) |
chr6_-_23839420 | 5.58 |
ENSMUST00000115358.2
ENSMUST00000163871.2 |
Cadps2
|
Ca2+-dependent activator protein for secretion 2 |
chr17_-_34862473 | 5.57 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr4_-_40239779 | 5.51 |
ENSMUST00000037907.6
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr2_-_51972990 | 5.48 |
ENSMUST00000145481.1
ENSMUST00000112705.2 |
Nmi
|
N-myc (and STAT) interactor |
chr3_+_142560351 | 5.44 |
ENSMUST00000106221.1
|
Gbp3
|
guanylate binding protein 3 |
chr5_-_105293699 | 5.41 |
ENSMUST00000050011.8
|
Gbp6
|
guanylate binding protein 6 |
chr3_+_142560108 | 5.41 |
ENSMUST00000128609.1
ENSMUST00000029935.7 |
Gbp3
|
guanylate binding protein 3 |
chr6_+_121245903 | 5.39 |
ENSMUST00000032198.9
|
Usp18
|
ubiquitin specific peptidase 18 |
chr7_+_51878967 | 5.34 |
ENSMUST00000051912.6
|
Gas2
|
growth arrest specific 2 |
chr17_+_34187545 | 5.31 |
ENSMUST00000170086.1
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr2_-_126933229 | 5.25 |
ENSMUST00000028844.4
|
Sppl2a
|
signal peptide peptidase like 2A |
chr8_+_61928081 | 5.22 |
ENSMUST00000154398.1
ENSMUST00000093485.2 ENSMUST00000156980.1 ENSMUST00000070631.7 |
Ddx60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr11_+_58199556 | 5.09 |
ENSMUST00000035266.4
ENSMUST00000094169.4 ENSMUST00000168280.1 ENSMUST00000058704.8 |
Igtp
Irgm2
|
interferon gamma induced GTPase immunity-related GTPase family M member 2 |
chr17_+_34187789 | 5.09 |
ENSMUST00000041633.8
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr7_+_51879041 | 4.91 |
ENSMUST00000107591.2
|
Gas2
|
growth arrest specific 2 |
chr1_+_156035705 | 4.87 |
ENSMUST00000111754.2
ENSMUST00000133152.1 |
Tor1aip2
|
torsin A interacting protein 2 |
chr19_+_56397100 | 4.85 |
ENSMUST00000026062.9
|
Casp7
|
caspase 7 |
chr2_-_77170534 | 4.81 |
ENSMUST00000111833.2
|
Ccdc141
|
coiled-coil domain containing 141 |
chr11_-_100704217 | 4.76 |
ENSMUST00000017974.6
|
Dhx58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr2_-_62646146 | 4.75 |
ENSMUST00000112459.3
ENSMUST00000028259.5 |
Ifih1
|
interferon induced with helicase C domain 1 |
chr16_+_43364145 | 4.73 |
ENSMUST00000148775.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr6_+_128662379 | 4.61 |
ENSMUST00000032518.4
|
Clec2h
|
C-type lectin domain family 2, member h |
chr3_+_60081861 | 4.60 |
ENSMUST00000029326.5
|
Sucnr1
|
succinate receptor 1 |
chr6_+_57580992 | 4.60 |
ENSMUST00000031817.8
|
Herc6
|
hect domain and RLD 6 |
chr4_+_41903610 | 4.58 |
ENSMUST00000098128.3
|
Gm21541
|
predicted gene, 21541 |
chr4_+_42114817 | 4.57 |
ENSMUST00000098123.3
|
Gm13304
|
predicted gene 13304 |
chr16_+_35938470 | 4.56 |
ENSMUST00000114878.1
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr15_+_99392882 | 4.56 |
ENSMUST00000023749.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_-_76243401 | 4.52 |
ENSMUST00000165738.1
ENSMUST00000075689.6 |
Parp10
|
poly (ADP-ribose) polymerase family, member 10 |
chr7_+_119526269 | 4.51 |
ENSMUST00000066465.1
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr6_-_85869128 | 4.45 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr18_-_60273267 | 4.44 |
ENSMUST00000090260.4
|
Gm4841
|
predicted gene 4841 |
chr18_-_61536522 | 4.43 |
ENSMUST00000171629.1
|
Arhgef37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr2_+_58755177 | 4.34 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr13_+_4434306 | 4.29 |
ENSMUST00000021630.8
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr17_-_34000257 | 4.29 |
ENSMUST00000087189.6
ENSMUST00000173075.1 ENSMUST00000172760.1 ENSMUST00000172912.1 ENSMUST00000025181.10 |
H2-K1
|
histocompatibility 2, K1, K region |
chr13_+_4059565 | 4.26 |
ENSMUST00000041768.6
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr16_-_24393588 | 4.21 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr2_+_58754910 | 4.21 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr16_+_35938972 | 4.19 |
ENSMUST00000023622.6
ENSMUST00000114877.1 |
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_+_142594847 | 4.10 |
ENSMUST00000029936.4
|
Gbp2b
|
guanylate binding protein 2b |
chr11_-_78984946 | 4.09 |
ENSMUST00000108268.3
|
Lgals9
|
lectin, galactose binding, soluble 9 |
chr3_-_98630309 | 4.02 |
ENSMUST00000044094.4
|
Hsd3b5
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
chr5_-_92348871 | 4.01 |
ENSMUST00000038816.6
ENSMUST00000118006.1 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr17_+_33919332 | 3.99 |
ENSMUST00000025161.7
|
Tapbp
|
TAP binding protein |
chr9_+_5345450 | 3.96 |
ENSMUST00000151332.1
|
Casp12
|
caspase 12 |
chr1_-_153851189 | 3.94 |
ENSMUST00000059607.6
|
5830403L16Rik
|
RIKEN cDNA 5830403L16 gene |
chr4_-_46536096 | 3.94 |
ENSMUST00000102924.2
|
Trim14
|
tripartite motif-containing 14 |
chr4_-_46536134 | 3.91 |
ENSMUST00000046897.6
|
Trim14
|
tripartite motif-containing 14 |
chr1_-_173490933 | 3.90 |
ENSMUST00000160565.2
|
Gm4955
|
predicted gene 4955 |
chr9_+_5345414 | 3.88 |
ENSMUST00000027009.4
|
Casp12
|
caspase 12 |
chr11_+_58215028 | 3.87 |
ENSMUST00000108836.1
|
Irgm2
|
immunity-related GTPase family M member 2 |
chr8_-_105938384 | 3.84 |
ENSMUST00000034369.8
|
Psmb10
|
proteasome (prosome, macropain) subunit, beta type 10 |
chr8_-_93279717 | 3.82 |
ENSMUST00000034178.8
|
Ces1f
|
carboxylesterase 1F |
chr14_-_7994563 | 3.81 |
ENSMUST00000026315.7
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr18_-_3299537 | 3.75 |
ENSMUST00000129435.1
ENSMUST00000122958.1 |
Crem
|
cAMP responsive element modulator |
chr10_-_34127955 | 3.69 |
ENSMUST00000062784.6
|
Fam26f
|
family with sequence similarity 26, member F |
chr1_+_13668739 | 3.66 |
ENSMUST00000088542.3
|
Xkr9
|
X Kell blood group precursor related family member 9 homolog |
chr17_+_37193889 | 3.64 |
ENSMUST00000038844.6
|
Ubd
|
ubiquitin D |
chr2_+_72054598 | 3.58 |
ENSMUST00000028525.5
|
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr6_-_31218421 | 3.58 |
ENSMUST00000115107.1
|
AB041803
|
cDNA sequence AB041803 |
chr11_-_78984831 | 3.50 |
ENSMUST00000073001.4
ENSMUST00000108269.3 |
Lgals9
|
lectin, galactose binding, soluble 9 |
chr6_-_125231772 | 3.48 |
ENSMUST00000043422.7
|
Tapbpl
|
TAP binding protein-like |
chr13_-_23710714 | 3.46 |
ENSMUST00000091707.6
ENSMUST00000006787.7 ENSMUST00000091706.6 |
Hfe
|
hemochromatosis |
chr1_-_172590463 | 3.44 |
ENSMUST00000065679.6
|
Slamf8
|
SLAM family member 8 |
chr6_+_34745952 | 3.41 |
ENSMUST00000123823.1
ENSMUST00000136907.1 ENSMUST00000126181.1 |
Cald1
|
caldesmon 1 |
chr2_+_68117713 | 3.40 |
ENSMUST00000112346.2
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr2_-_24049389 | 3.38 |
ENSMUST00000051416.5
|
Hnmt
|
histamine N-methyltransferase |
chr7_+_104244449 | 3.38 |
ENSMUST00000106849.2
ENSMUST00000060315.5 |
Trim34a
|
tripartite motif-containing 34A |
chr17_+_35439155 | 3.37 |
ENSMUST00000071951.6
ENSMUST00000078205.7 ENSMUST00000116598.3 ENSMUST00000076256.7 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr5_+_67260794 | 3.29 |
ENSMUST00000161369.1
|
Tmem33
|
transmembrane protein 33 |
chr8_+_70083509 | 3.24 |
ENSMUST00000007738.9
|
Hapln4
|
hyaluronan and proteoglycan link protein 4 |
chr1_+_156035392 | 3.21 |
ENSMUST00000111757.3
|
Tor1aip2
|
torsin A interacting protein 2 |
chr7_+_104244465 | 3.21 |
ENSMUST00000106848.1
|
Trim34a
|
tripartite motif-containing 34A |
chr2_-_51973219 | 3.19 |
ENSMUST00000028314.2
|
Nmi
|
N-myc (and STAT) interactor |
chr15_+_75862310 | 3.18 |
ENSMUST00000023238.4
|
Gsdmd
|
gasdermin D |
chr16_-_35939082 | 3.18 |
ENSMUST00000081933.7
ENSMUST00000114885.1 |
Dtx3l
|
deltex 3-like (Drosophila) |
chr13_+_51846673 | 3.11 |
ENSMUST00000021903.2
|
Gadd45g
|
growth arrest and DNA-damage-inducible 45 gamma |
chr7_+_107567445 | 3.11 |
ENSMUST00000120990.1
|
Olfml1
|
olfactomedin-like 1 |
chr7_+_104244496 | 3.05 |
ENSMUST00000106854.1
ENSMUST00000143414.1 |
Trim34a
|
tripartite motif-containing 34A |
chr3_+_27317028 | 2.96 |
ENSMUST00000046383.5
ENSMUST00000174840.1 |
Tnfsf10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr3_+_142530329 | 2.94 |
ENSMUST00000171263.1
ENSMUST00000045097.9 |
Gbp7
|
guanylate binding protein 7 |
chr15_-_76014318 | 2.91 |
ENSMUST00000060807.5
|
Fam83h
|
family with sequence similarity 83, member H |
chr6_+_124512615 | 2.90 |
ENSMUST00000068593.7
|
C1ra
|
complement component 1, r subcomponent A |
chr13_+_33004528 | 2.90 |
ENSMUST00000006391.4
|
Serpinb9
|
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
chr3_+_81932601 | 2.83 |
ENSMUST00000029649.2
|
Ctso
|
cathepsin O |
chr4_+_135728116 | 2.83 |
ENSMUST00000102546.3
|
Il22ra1
|
interleukin 22 receptor, alpha 1 |
chr5_-_105139539 | 2.81 |
ENSMUST00000100961.4
ENSMUST00000031235.6 ENSMUST00000100962.3 |
Gbp9
Gbp8
Gbp4
|
guanylate-binding protein 9 guanylate-binding protein 8 guanylate binding protein 4 |
chr18_-_3299452 | 2.81 |
ENSMUST00000126578.1
|
Crem
|
cAMP responsive element modulator |
chr1_-_155146755 | 2.80 |
ENSMUST00000027744.8
|
Mr1
|
major histocompatibility complex, class I-related |
chr13_+_74639866 | 2.76 |
ENSMUST00000169114.1
|
Erap1
|
endoplasmic reticulum aminopeptidase 1 |
chr12_+_37241633 | 2.75 |
ENSMUST00000049874.7
|
Agmo
|
alkylglycerol monooxygenase |
chr5_-_105110292 | 2.74 |
ENSMUST00000031238.6
|
Gbp9
|
guanylate-binding protein 9 |
chr2_+_43555321 | 2.70 |
ENSMUST00000028223.2
|
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr4_-_40239700 | 2.69 |
ENSMUST00000142055.1
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr6_-_38354243 | 2.68 |
ENSMUST00000114900.1
|
Zc3hav1
|
zinc finger CCCH type, antiviral 1 |
chr19_-_7966000 | 2.68 |
ENSMUST00000182102.1
ENSMUST00000075619.4 |
Slc22a27
|
solute carrier family 22, member 27 |
chr12_+_37241729 | 2.67 |
ENSMUST00000160768.1
|
Agmo
|
alkylglycerol monooxygenase |
chr18_+_60293372 | 2.66 |
ENSMUST00000171297.1
|
F830016B08Rik
|
RIKEN cDNA F830016B08 gene |
chr15_-_76307101 | 2.66 |
ENSMUST00000171340.1
|
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr5_-_91402905 | 2.64 |
ENSMUST00000121044.2
|
Btc
|
betacellulin, epidermal growth factor family member |
chr3_-_86999284 | 2.64 |
ENSMUST00000063869.5
ENSMUST00000029717.2 |
Cd1d1
|
CD1d1 antigen |
chr16_+_26581704 | 2.63 |
ENSMUST00000096129.2
ENSMUST00000166294.2 ENSMUST00000174202.1 ENSMUST00000023156.6 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr3_+_142496924 | 2.61 |
ENSMUST00000090127.2
|
Gbp5
|
guanylate binding protein 5 |
chr9_-_50555170 | 2.60 |
ENSMUST00000119103.1
|
Bco2
|
beta-carotene oxygenase 2 |
chr10_+_39612934 | 2.59 |
ENSMUST00000019987.6
|
Traf3ip2
|
TRAF3 interacting protein 2 |
chr8_-_3748941 | 2.58 |
ENSMUST00000012847.1
|
Cd209a
|
CD209a antigen |
chr2_+_43555342 | 2.57 |
ENSMUST00000112826.1
ENSMUST00000050511.6 |
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr1_+_130865669 | 2.57 |
ENSMUST00000038829.5
|
Faim3
|
Fas apoptotic inhibitory molecule 3 |
chr2_-_126783416 | 2.57 |
ENSMUST00000130356.1
ENSMUST00000028842.2 |
Usp50
|
ubiquitin specific peptidase 50 |
chr2_+_27676440 | 2.55 |
ENSMUST00000129514.1
|
Rxra
|
retinoid X receptor alpha |
chr17_+_35262730 | 2.55 |
ENSMUST00000172785.1
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr17_+_35470083 | 2.51 |
ENSMUST00000174525.1
ENSMUST00000068291.6 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr12_+_37242030 | 2.50 |
ENSMUST00000160390.1
|
Agmo
|
alkylglycerol monooxygenase |
chr6_-_54972603 | 2.49 |
ENSMUST00000060655.8
|
Nod1
|
nucleotide-binding oligomerization domain containing 1 |
chr8_-_111338152 | 2.46 |
ENSMUST00000056157.7
ENSMUST00000120432.1 |
Mlkl
|
mixed lineage kinase domain-like |
chr14_+_41105359 | 2.46 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr10_-_92375367 | 2.40 |
ENSMUST00000182870.1
|
Gm20757
|
predicted gene, 20757 |
chr19_+_8898090 | 2.39 |
ENSMUST00000096246.3
|
Ganab
|
alpha glucosidase 2 alpha neutral subunit |
chr17_+_31433054 | 2.37 |
ENSMUST00000136384.1
|
Pde9a
|
phosphodiesterase 9A |
chr8_-_3878549 | 2.36 |
ENSMUST00000011445.6
|
Cd209d
|
CD209d antigen |
chr10_+_128270546 | 2.34 |
ENSMUST00000105238.3
ENSMUST00000085708.2 |
Stat2
|
signal transducer and activator of transcription 2 |
chr8_-_84800024 | 2.34 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr19_-_24861828 | 2.34 |
ENSMUST00000047666.4
|
Pgm5
|
phosphoglucomutase 5 |
chr8_-_84800344 | 2.33 |
ENSMUST00000099070.3
|
Nfix
|
nuclear factor I/X |
chr4_+_155582476 | 2.32 |
ENSMUST00000105612.1
|
Nadk
|
NAD kinase |
chr2_-_77170592 | 2.32 |
ENSMUST00000164114.2
ENSMUST00000049544.7 |
Ccdc141
|
coiled-coil domain containing 141 |
chr3_+_138313279 | 2.30 |
ENSMUST00000013455.6
ENSMUST00000106247.1 |
Adh6a
|
alcohol dehydrogenase 6A (class V) |
chr10_+_4611971 | 2.29 |
ENSMUST00000105590.1
ENSMUST00000067086.7 |
Esr1
|
estrogen receptor 1 (alpha) |
chr19_-_21472552 | 2.28 |
ENSMUST00000087600.3
|
Gda
|
guanine deaminase |
chr2_+_19371636 | 2.28 |
ENSMUST00000023856.8
|
Msrb2
|
methionine sulfoxide reductase B2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 38.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
7.3 | 22.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
4.4 | 13.1 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
3.5 | 3.5 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
3.5 | 41.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
3.3 | 10.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
3.1 | 176.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
3.1 | 9.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.9 | 8.7 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
2.9 | 17.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.8 | 8.3 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.1 | 2.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
2.0 | 12.2 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
2.0 | 10.0 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.9 | 17.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.8 | 9.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.6 | 4.9 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
1.6 | 6.4 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
1.5 | 4.5 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.5 | 11.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.5 | 1.5 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.4 | 4.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.3 | 5.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.3 | 3.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.1 | 3.4 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
1.1 | 7.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 2.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.9 | 3.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.9 | 3.5 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.9 | 70.7 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.8 | 2.5 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.8 | 13.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 14.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 2.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.7 | 6.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 | 8.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 4.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.7 | 9.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 3.4 | GO:1902623 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) negative regulation of neutrophil migration(GO:1902623) |
0.7 | 2.0 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.7 | 5.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.0 | GO:0060809 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.6 | 8.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 1.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.7 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.6 | 1.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.5 | 1.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.5 | 6.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 2.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.5 | 1.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.1 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.5 | 2.6 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.5 | 8.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.5 | 3.4 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 9.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.5 | 1.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 0.4 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.4 | 17.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 3.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 2.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 2.5 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 11.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.4 | 0.8 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.4 | 2.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 12.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 2.3 | GO:0060751 | Sertoli cell proliferation(GO:0060011) prostate epithelial cord elongation(GO:0060523) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.4 | 1.5 | GO:0010901 | negative regulation of cytokine secretion involved in immune response(GO:0002740) regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.4 | 1.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 3.8 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.4 | 10.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 1.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
0.4 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 1.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.4 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.3 | 1.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 1.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.3 | 7.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 2.6 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.9 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 2.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 1.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.9 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.3 | 0.3 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) |
0.3 | 2.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.3 | 2.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 2.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 1.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.3 | 1.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 0.5 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 1.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 1.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 1.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 2.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 1.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 0.8 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.3 | 4.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.3 | 13.2 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 1.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 7.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 2.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 2.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 1.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.7 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 0.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 1.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 2.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.2 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.4 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 1.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.2 | GO:2000911 | positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
0.2 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 1.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 1.8 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.2 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.7 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 0.7 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 3.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 2.5 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.2 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.3 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.2 | 0.5 | GO:0051030 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) |
0.2 | 7.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 0.5 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 2.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 2.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 1.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.5 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 0.9 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 2.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 5.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 4.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 1.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.4 | GO:0071288 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) cellular response to mercury ion(GO:0071288) |
0.1 | 2.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 1.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 3.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 15.3 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.5 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 2.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 1.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 4.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 2.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 1.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 4.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 19.0 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 1.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.7 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.5 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.8 | GO:0048245 | mast cell chemotaxis(GO:0002551) eosinophil chemotaxis(GO:0048245) |
0.1 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 1.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 2.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 1.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 1.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 10.8 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.1 | 1.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 1.2 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.9 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.1 | 0.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.3 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 2.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 3.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 4.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 1.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 2.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 1.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.1 | 0.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 2.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.2 | GO:1903999 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.0 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 1.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 3.0 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 5.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 1.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 3.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 2.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.5 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 2.3 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.1 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.0 | 0.6 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 1.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 1.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.9 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 6.1 | GO:0009116 | nucleoside metabolic process(GO:0009116) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.2 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.0 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 58.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
2.7 | 32.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.2 | 11.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.1 | 17.0 | GO:0042825 | TAP complex(GO:0042825) |
1.6 | 6.5 | GO:0097447 | dendritic tree(GO:0097447) |
1.1 | 8.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 14.1 | GO:0044754 | autolysosome(GO:0044754) |
0.9 | 38.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.9 | 5.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.9 | 7.8 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 3.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 1.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 2.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 2.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 3.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 1.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 17.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 2.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.3 | 1.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 2.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 3.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 1.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 23.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.7 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 6.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 2.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 6.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0043512 | inhibin A complex(GO:0043512) |
0.1 | 1.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 3.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.4 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 16.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 50.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 17.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 3.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 1.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 5.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 10.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 3.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 6.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 20.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 2.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 5.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 6.4 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 3.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 2.4 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 27.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 1.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.5 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 3.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 7.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 4.6 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 2.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 66.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 26.7 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 2.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
3.9 | 39.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.6 | 7.9 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
2.4 | 22.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
2.4 | 17.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.4 | 16.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
2.3 | 9.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
2.2 | 8.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.0 | 24.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.0 | 11.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.7 | 6.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.7 | 8.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.7 | 10.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.4 | 4.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.4 | 4.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.4 | 4.1 | GO:0019002 | GMP binding(GO:0019002) |
1.3 | 5.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.3 | 7.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.1 | 7.6 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 4.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.0 | 38.3 | GO:0008009 | chemokine activity(GO:0008009) |
1.0 | 10.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 10.8 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 9.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 7.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 13.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.9 | 13.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 4.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.9 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 3.4 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.8 | 2.5 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.8 | 2.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 18.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.8 | 2.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.7 | 2.0 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.7 | 7.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 2.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.7 | 5.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.9 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.6 | 1.9 | GO:0005118 | sevenless binding(GO:0005118) |
0.6 | 4.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 15.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.6 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 2.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.5 | 6.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 1.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 1.5 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.5 | 3.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 8.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 2.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.4 | 3.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 1.4 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.3 | 1.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 2.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 5.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 2.4 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 2.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 2.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 2.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 8.1 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 2.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 4.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 2.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 92.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 2.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 8.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 7.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 4.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 4.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 4.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 1.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 2.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.2 | 5.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 3.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 16.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 0.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 2.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 15.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 18.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 2.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 4.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 4.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 4.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 2.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 13.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 16.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 2.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 5.5 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 2.5 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 3.4 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 1.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 2.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 3.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 3.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 1.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 2.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 1.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 1.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 2.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 2.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 2.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 8.0 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 2.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 11.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 13.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 29.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 39.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 16.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 13.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 9.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 5.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 6.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 3.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 4.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 6.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 10.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 3.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 21.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.0 | 13.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.9 | 16.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 15.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.8 | 14.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 15.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 27.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 2.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 15.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 5.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 6.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 20.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 9.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 7.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 15.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 3.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 2.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 1.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 6.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 10.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 7.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 15.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 9.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 4.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 8.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 4.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 5.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 2.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 2.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 2.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |